Novartis Appealing Doan's Pills FTC $8 Mil. Corrective Ad Order
This article was originally published in The Tan Sheet
Executive Summary
Novartis plans to "file an appeal with a federal court" contesting the Federal Trade Commission's May 27 order requiring corrective advertising and labeling for Doan's Pills ad claims. In a 4-0 vote, the commission reversed a March 1998 administrative law judge's decision not to impose corrective advertising to remedy what FTC charges were deceptive superiority claims.
You may also be interested in...
Doan's FTC Correction Requirement Is "Punitive" And "Irrational" - Novartis
Novartis is asking the Federal Trade Commission to stay the corrective advertising requirement in FTC's final order in the case regarding Doan's Pills advertising claims. The firm asserts FTC's requirement for corrective ad copy is punitive in nature and "irrational" in its application for a stay of Part IV of the commission's final order and decision. FTC had concluded certain superiority claims used in Doan's ads were deceptive.
Doan's FTC Correction Requirement Is "Punitive" And "Irrational" - Novartis
Novartis is asking the Federal Trade Commission to stay the corrective advertising requirement in FTC's final order in the case regarding Doan's Pills advertising claims. The firm asserts FTC's requirement for corrective ad copy is punitive in nature and "irrational" in its application for a stay of Part IV of the commission's final order and decision. FTC had concluded certain superiority claims used in Doan's ads were deceptive.
Doan's FTC Correction Requirement Is "Punitive" And "Irrational" - Novartis
Novartis is asking the Federal Trade Commission to stay the corrective advertising requirement in FTC's final order in the case regarding Doan's Pills advertising claims. The firm asserts FTC's requirement for corrective ad copy is punitive in nature and "irrational" in its application for a stay of Part IV of the commission's final order and decision. FTC had concluded certain superiority claims used in Doan's ads were deceptive.